To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

October 03, 2019___

Today's Rundown

Featured Story

After failed cancer test, Tocagen slashes staff

Just last month, Tocagen posted a failed late-stage trial for its gene therapy attempt to boost survival in brain cancer and said it was seeking an “operational review.”

Top Stories

Adicet Bio reels in $80M to push lymphoma program into the clinic

Adicet Bio picked up $80 million in series B financing to develop a suite of “off-the-shelf" T-cell therapies. The cash will push a treatment for non-Hodgkin lymphoma into the clinic and support development of Adicet’s gamma delta T-cell platform.

Tenaya Therapeutics bags $92M to develop triple threat for heart disease

Although heart disease is the leading cause of death worldwide, it’s an area that hasn’t seen as much interest or investment as others. With a multipronged approach and a fresh infusion of $92 million, Tenaya Therapeutics is trying to change that.

[Sponsored] Boost clinical supply chain performance using digital technologies

Personalized medicine, greater drug portfolio complexity, and quicker clinical development is raising the stakes. How can digital provide a boost in clinical supply chain performance?

Icosavax raises $51M to take VLP RSV vaccine into humans

Icosavax has raised a $51 million series A round to take respiratory syncytial virus vaccine IVX-121 through phase 1b in older adults. The vaccine is built on computationally designed self-assembling viruslike particle technology.

Third Rock's Goldfinch bags rights to Takeda kidney disease drug

Goldfinch Bio has secured the global rights to a peripherally restricted cannabinoid receptor 1 monoclonal antibody from Takeda. The Third Rock startup plans to file an IND for the treatment for rare and metabolic kidney diseases next year.

Resources

[Whitepaper] The Next Generation of Trial Master File Systems

Simplified filing, improved oversight, audit readiness: is your eTMF system delivering best-in-class benefits?

[Whitepaper] Cortellis Q2 2019 M&A report

Download this report for full details of Life sciences M&As in the second quarter of 2019 with notes and trends.

[Whitepaper] SOAR™ Model Manages Data From Source to Submission

Find out how it leverages real-world data and novel IntElligo Research Stack™ technology to help researchers battle rising costs, cumbersome processes, and stagnant participation — bridging the gap between research and care.

[Whitepaper] Successful Clinical Trials in the Era of Genetics-based Medicine

Download this complimentary guide paper that explores key strategies for a successful genetics-informed clinical trial.

[Whitepaper] Best Practices for Incorporating Real World Imaging Data into RWE Programs

The time has finally come when medical imaging can be effectively utilized into the RWE process. Read the whitepaper on the best practices for incorporating Real World Imaging.™

[Whitepaper] Synthesizing Success: Six Principles for Getting Pharmaceutical Development Right from the Start

Is your API development on track?

[Whitepaper] Advanced Analytical Approaches for Accelerated Development of Gene Therapy Products

Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products.

[Whitepaper] Webinar Benchmarks Report for Life Sciences 2019

Compare digital program performance and audience engagement among your life sciences peers.

[Webinar] Clinically Integrated Networks: A Growing Disruptor in American Healthcare

Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem.

[Whitepaper] Fail Fast. Succeed Faster.

Slashing your R&D costs is easier than you think.

[Whitepaper] Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases

A global landscape study of funding trends and innovations.

[Whitepaper] Understanding Precision Medicine in Oncology

White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies.

[Article] Why Market Leaders Outsource IT Requirements For A Competitive Edge

Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage.

[Whitepaper] From Complex to Controlled: Advanced Data Management Strategies for Advanced Therapies

Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success.

[Whitepaper] Advancing Healthcare Market Intelligence With Smart Search Technology

AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy.

[Whitepaper] What's Your Lab Trying to Tell You? Listen with Connected IoT Sensors

Your lab is talking to you, are you listening?

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events